Saluda Medical shares slump on Australian market debut
Reuters
Dec 05, 2025
Saluda Medical shares slump on Australian market debut
Dec 5 (Reuters) - Australian-listed shares of Saluda Medical SLD.AX dropped over 34% on Friday after raising A$231 million ($152.67 million) in its debut on the Australian Securities Exchange.
Saluda, a U.S.-based medical device company developing neuromodulation treatments for chronic neurological conditions, sold 87.1 million new CHESS Depositary Interests at A$2.65, valuing the company at about A$775 million at listing.
The stock began trading at A$1.745, against a 0.1% drop on the Australian benchmark S&P/ASX 200 index .AXJO.
($1 = 1.5131 Australian dollars)
(Reporting by Roshan Thomas in Bengaluru; Editing by Alan Barona)
((Roshan.Thomas@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.